Liver Surgery in New Zealand
The liver is a remarkable organ that plays a vital role in keeping us healthy. It's truely amazing as it has the ability to regenerate after surgery.
Liver surgery is a specialised area of general surgery involving the assessment and management of both benign and malignant liver conditions. Dr Peter Carr-Boyd provides expert evaluation of liver pathology and performs careful surgical management within a multidisciplinary framework
Conditions Assessed and Treated
Liver surgery may be recommended to treat a range of benign and malignant liver conditions, either to relieve symptoms, prevent complications, or treat cancer.
-
Liver cysts that are large, painful, infected, or causing pressure symptoms
-
Benign liver tumours, such as focal nodular hyperplasia or hepatic adenomas, when they cause symptoms or carry a risk of bleeding or malignant change
-
Liver metastases, most commonly from colorectal cancer and neuroendocrine tumours where surgery can significantly improve long-term outcomes
-
Primary liver cancers, including hepatocellular carcinoma (HCC), cholangiocarcinoma, and hepatoblastoma
Why Choose a Specialist Liver Surgeon?
Choosing a specialist liver surgeon is critical when managing liver disease or considering liver surgery. Dr Peter Carr-Boyd is an experienced Hepatopancreatobiliary (HPB) surgeon and a currently practising adult and paediatric liver transplant surgeon, with expertise across the full spectrum of benign and malignant liver conditions.
This advanced specialist training ensures that liver surgery is performed safely, precisely, and to the highest international standards. Dr Carr-Boyd’s experience in complex liver resections and liver transplantation allows careful assessment of surgical risk, preservation of healthy liver tissue, and optimal timing of intervention.
Dr Carr-Boyd works within a specialist multidisciplinary liver team, collaborating closely with medical and radiation oncologists, hepatologists, interventional and diagnostic radiologists, pathologists, and specialist anaesthetists. Every oncology patient is discussed in a multidisciplinary team (MDT) meeting, where the decision to proceed with surgery, the type and timing of surgery, and the role of other treatments—such as chemotherapy, immunotherapy, or radiotherapy—are carefully considered.
If liver surgery is recommended, Dr Carr-Boyd will clearly explain the rationale, expected benefits, potential risks, alternatives, and recovery process, enabling you to make a well-informed, confident decision. This evidence-based, patient-centred approach maximises outcomes, minimises complications, and ensures you receive the right treatment, at the right time, for your individual condition.
Your safety is my priority!
Dr Carr-Boyd is an active participant in Auckland City Hospital’s Upper Gastrointestinal multidisciplinary team meeting, as well as the National Neuroendocrine and the HCC (Hepatocellular carcinoma) multidisciplinary team meetings. Together, the team help to ensure patients with cancer in the liver are thoroughly and appropriately assessed, and that recommendations for treatment are based on thoughtful consideration by a team of specialists including surgeons, oncologists, radiologists and pathologists.